State
72,986 recalls have nationwide distribution and so reach Nevada. 5,692 additional recalls listed Nevada specifically in their distribution scope.
Of the 5,692 recalls naming Nevada we have scored against our rubric, 951 (17%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,476 (26%) are Severe.
Which agencies issued them
These figures cover only the 5,692 recalls whose distribution notice names Nevada specifically. The 72,986 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Glenmark Pharmaceuticals is voluntarily recalling Cetirizine HCL 10mg tablets distributed nationwide. The recall was initiated due to Current Good Manufacturing Practice deviations.
Glenmark Pharmaceuticals is recalling Lacosamide 100mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The firm initiated this voluntary recall on March 13, 2025.
Glenmark Pharmaceuticals Inc., USA is recalling Frovatriptan Succinate 2.5mg tablets nationwide due to current Good Manufacturing Practice (CGMP) deviations. The FDA has classified this as a Class II recall.
Glenmark Pharmaceuticals is recalling Rufinamide 200mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects certain lot numbers with July 2025 expiration dates.
Medline Industries is recalling Wayson Hydrocolloid Bandages because the sterility of the devices may be compromised. Affected products include multiple models distributed nationwide and internationally.
Glenmark Pharmaceuticals Inc. is recalling Pravastatin Sodium 20mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects specific lot numbers distributed across the U.S.
Glenmark Pharmaceuticals Inc. is recalling specific lots of Nitroglycerin 0.3MG sublingual tablets distributed nationwide due to Current Good Manufacturing Practice (CGMP) deviations. Patients should consult their healthcare provider.
Asegua Therapeutics is recalling 18,541 cartons of Sofosbuvir and Velpatasvir tablets nationwide due to defective blister packs that are not properly sealed, resulting in loose tablets in cartons. No illnesses or injuries have been reported.
Sun Pharmaceutical Industries is recalling Gabapentin Capsules, USP 300 mg, due to cross contamination. The recall affects approximately 12,876 bottles distributed nationwide.
Sun Pharmaceutical Industries Inc. is recalling Gabapentin Capsules 400 mg due to cross contamination. The recall affects 852 bottles distributed nationwide.
Audi is recalling 2022-2023 RS E-TRON GT and E-TRON GT vehicles because a wiring fault may deactivate the front passenger air bag, increasing injury risk in a crash.
Chrysler is recalling certain 2023-2025 Alfa Romeo Tonale and Dodge Hornet vehicles because the display module may not show the rearview camera image, failing FMVSS 111.
Goodyear is recalling specific Cooper Discoverer Stronghold AT tires because they lack the required week and year code. This prevents owners from determining the tire's age or recall status.
Nova Bus is recalling specific ZF brake chambers sold as replacement parts for buses because improper manufacturing may cause air leaks, increasing the risk of unexpected braking, overheating, or fire.
Prevost is recalling 2025 H3-45 and X3-45 motorcoaches because emergency exit windows may be difficult to open, increasing injury risk.
Oshkosh is recalling 216 model-year 2025 NGDV vehicles because the rearview camera image may not display in reverse, increasing crash risk.
Forest River is recalling certain 2024-2025 trailers with a removable step assembly because the clip-on bracket mounting bolt may allow the steps to detach in use.
Maserati is recalling 2024 Granturismo vehicles because the tire label may detach, potentially leading to vehicle overload and increased crash risk.
Mercedes-Benz is recalling 2024 E 350 and E 450 vehicles because improperly secured electrical ground connections may overheat and increase the risk of a fire.
Ford is recalling 2024-2025 E-Transit Chassis vehicles because battery tray rails may crack, allowing water entry that could cause a fire.
Ford is recalling 2017-2018 F-150, Expedition, and Lincoln Navigator vehicles because a brake master cylinder defect may cause fluid leaks, reducing braking ability and increasing crash risk.
Jayco is recalling 2025-2026 Entegra Aspire, Anthem, and Cornerstone motorhomes because a fuel filter housing may leak, increasing fire risk.
Ford is recalling certain 2024 Ranger and Lincoln Nautilus vehicles previously repaired incorrectly under recall 24V-597, because windows may not reverse on detecting an object.
USDA FSIS issued a public health alert for various soup and bowl products potentially contaminated with wood in cilantro. Consumers in Illinois, Indiana, Michigan, and Ohio should not consume these items.
Ford is recalling certain 2025 Explorer vehicles because the powertrain control module may reset while driving, which can damage the park system or cause an engine stall.